Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis.
Denosumab Discontinuation in Patients Treated for Low Bone Density and Osteoporosis. Endocrinol Metab Clin North Am. 2021 06; 50(2):205-222.
View in:
PubMed
subject areas
Bone Density
Bone Density Conservation Agents
Bone Remodeling
Denosumab
Female
Humans
Osteoporosis
Osteoporosis, Postmenopausal
authors with profiles
Laura Dickens